Quick Overview: While CFTR modulators were a significant breakthrough, gaps in understanding and challenges remain. During plenary 1 of the ... As cystic fibrosis care enters a new era of personalized medicine and transformative therapies, addressing equity is critical to ... As people with cystic fibrosis live longer, fuller lives, we must adapt to the evolving challenges and opportunities that come with ...

Nacfc 2025 6 Years Of - Detailed Overview & Context

While CFTR modulators were a significant breakthrough, gaps in understanding and challenges remain. During plenary 1 of the ... As cystic fibrosis care enters a new era of personalized medicine and transformative therapies, addressing equity is critical to ... As people with cystic fibrosis live longer, fuller lives, we must adapt to the evolving challenges and opportunities that come with ... Clinic time for patients, their families, and care team members alike is extremely valuable. The constant struggle is how to make ... As cystic fibrosis care continues to evolve, the recent approval of Alfytrek marks another pivotal moment in treatment options, ... In this webinar, Drs. Cori Daines and George Solomon shared some of the research and care highlights from the

This session explores the most recent advancements in clinical research design, implementation, and therapeutic innovation. This session highlights how pulmonary exacerbations (PEx) and PEx management have changed in the era of cystic fibrosis ... The integration of formalized surveys into the clinic workflow aims to enhance care for patients and families through structured ... Aunque los moduladores CFTR (proteína reguladora de la conductancia transmembrana de la fibrosis quística) supusieron un ... People with cystic fibrosis experience recurrent and often chronic respiratory and GI infections, even in the presence of highly ... This symposium explores the evolving landscape of endocrine health in people with cystic fibrosis across all stages of life.

This session incorporates clinical and basic science to explore the physiologic mechanisms that cause gastrointestinal ... This session explores state-of-the-art clinical trials and investigator lea studies focusing on lung health and pulmonary outcomes ...

Photo Gallery

NACFC 2025| 6 Years of Highly Effective Modulator Therapy & Beyond: Reflecting Back, Looking Forward
NACFC 2025 | S06: Cure (or Close) for All
NACFC 2025 | A Breath of Fresh Age: Redefining Growing Older With Cystic Fibrosis
NACFC 2025 | S01: Tips & Tricks for Running an Efficient Multidisciplinary Cystic Fibrosis Clinic
NACFC 2025 | Until It’s Done for Everyone
NACFC 2025 | DG06: Chameleon Color Change: Adapting to the Changing CF Pharmacy Landscape
CF Foundation | NACFC 2025 Highlights Webinar and Q+A
NACFC 2025 | W20: Cutting-edge Clinical Trials: Insights & Updates
NACFC 2025 | S08: Rethinking Pulmonary Management in the Current Era of Cystic Fibrosis
NACFC 2025 | LL01: So Many Guidelines, So Little Time
NACFC 2025 | 6 Años de Tratamiento Modulador Eficaz: Reflexionar y Mirar Adelante
NACFC 2025 | W19: Epidemiology & Clinical Impact of Infection in Cystic Fibrosis
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored